Management of atherothrombosis with clopidogrel in high-risk patients with recent transient ischaemic attack or ischaemic stroke (MATCH): Study design and baseline data

Cerebrovascular Diseases

Volumn 17, Issue 2-3, 2004, Pages 253-261

  Diener, Hans Christoph ^a   Bogousslavsky, Julien ^b   Brass, Lawrence M ^c   Cimminiello, Claudio ^d   Csiba, Laszlo ^e   Kaste, Markku ^f   Leys, Didier ^g   Matias Guiu, Jordi ^h   Rupprecht, Hans Jürgen ⁱ  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d DESIO HOSPITAL   (Italy)

^e UNIVERSITY OF DEBRECEN   (Hungary)

^f UNIVERSITY OF HELSINKI   (Finland)

^g UNIV LILLE   (France)

^h HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

ⁱ JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Acetylsalicylic acid; Antiplatelet therapy; Atherothrombosis; Clopidogrel; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PLACEBO;

ACUTE DISEASE; ADULT; AGE; AGED; ARTERY DISEASE; ARTICLE; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HEART INFARCTION; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RISK FACTOR; STABLE ANGINA PECTORIS; STANDARDIZATION; THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS; VASCULAR DISEASE;

ARTERIOSCLEROSIS; ASPIRIN; CEREBROVASCULAR ACCIDENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; PLATELET AGGREGATION INHIBITORS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; THROMBOSIS; TICLOPIDINE;

EID: 1942531422     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076962     Document Type: Article

References (20)

1. Weimar C, Roth MP, Zillessen G, Glahn J, Wimmer ML, Busse O, Haberl RL, Diener HC, on behalf of the German Stroke Data Bank Collaborators: Complications following acute ischemic stroke. Eur Neurol 2002;48:133-140.
2. Jorgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS: Stroke recurrence: Predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology 1997;48:891-895.
3. Sandercock P, Tangkanakul C: Very early prevention of stroke recurrence. Cerebrovasc Dis 1997;7(suppl 1):10-15.
4. Johnston SC, Gress DR, Browner WS, Sidney S: Short-term prognosis after emergency department diagnosis of TIA. JAMA 2000;284:2901-2906.
5. Antiplatelet Trialists' Collaboration: Collaborative overview of randomised trials of antiplatelet therapy. I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994;308:81-106.
6. Antithrombotic Trialists' Collaboration: Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;524:71-86.
7. CAPRIE Steering Committee: A randomised, blinded trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996;348:1329-1339.
8. Bhatt DL, Marso SP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ: Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. Am J Cardiol 2002;90:625-628.
9. Bhatt DL, Chew DP, Hirsch AT, Ringleb PA, Hacke W, Topol EJ: Superiority of clopidogrel versus aspirin in patients with prior cardiac surgery. Circulation 2001;103:363-368.
10. Bhatt DL, Foody J, Hirsch AT, Ringleb P, Hacke W, Topol EJ: Complementary, additive benefit of clopidogrel and lipid-lowering therapy in patients with atherothrombosis. J Am Coll Cardiol 2000;35(suppl A):326.
11. Ringleb PA, Bhatt DL, Hirsch AT, Topol EJ, Hacke W, on behalf of the CAPRIE Investigators: The benefit of clopidogrel over aspirin is amplified in patients with a prior history of ischemic events. Stroke 2004;35:528-532.
12. Harker LA, Marzec UM, Kelly AB, Chronos NRF, Sundell IB, Hanson SR, Herbert J-M: Clopidogrel inhibition of stent, graft, and vascular thrombogenesis with antithrombotic enhancement by aspirin in nonhuman primates. Circulation 1998;22:2461-2469.
13. Herbert JM, Dol F, Bernat A, Falotico R, Lalé A, Savi P: The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit. Thromb Haemost 1998;80:512-518.
14. Makkar RR, Eigler S, Kaul S, Frimerman A, Nakamura M, Shah PK, Forrester JS, Herbert JM, Litvack F: Effects of clopidogrel, aspirin and combined therapy in a porcine ex vivo model of high-shear induced stent thrombosis. Eur Heart J 1998;19:1538-1546.
15. Moshfegh K, Redondo M, Julmy F, Wuillemin WA, Gebauer MU, Haeberli A, Meyer BJ: Antiplatelet effects of clopidogrel compared with aspirin after myocardial infarction: Enhanced inhibitory effects of combination therapy. J Am Coll Cardiol 2000;36:699-705.
16. Diener HC, Cuhna L, Forbes C, Sivenius J, Smets P, Lowenthal A: European Stroke Prevention Study 2:Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci 1996;143:1-13.
17. The Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without S-T segment elevation. N Engl J Med 2001;345:494-502.
18. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ, for the CREDO Investigators: Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: A randomized controlled trial. JAMA 2002;288:2411-2420.
19. Adams HP Jr, Bendixen BH, Kappelle JL, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke: Definitions for use in a multicenter clinical trial. Stroke 1993;24:35-41.
20. Peters RJG, Mehta SR, Fox KAA, Zhao F, Lewis BS, Kopecky S, Diaz R, Commerford PJ, Valentin V, Yusuf S, for the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators: Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: Observations from the Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study. Circulation 2003;108:1682-1687.